CPIX

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) is a specialty pharmaceutical company founded in 1999 and headquartered in Nashville, Tennessee. The company went public in August 2009 and focuses on acquiring, developing, and commercializing prescription medications primarily for hospital acute care settings. Cumberland has built a portfolio of FDA-approved branded pharmaceutical products while also developing a clinical pipeline of investigational drugs targeting rare diseases and unmet medical needs.